Alexion Pharmaceuticals, Inc. (ALXN)

102.02
0.78 0.77
NASDAQ
Prev Close 101.24
Open 100.79
Day Low/High 100.78 / 102.48
52 Wk Low/High 72.67 / 125.52
Volume 386.60K
Exchange NASDAQ
Shares Outstanding 219.17B
Market Cap 22.33B
P/E Ratio 27.17
Div & Yield N.A. (N.A)
Fitz Bits: A Stalwart Uptrend

Fitz Bits: A Stalwart Uptrend

Use this Alexion pullback as a buying opportunity.

The Week Ahead: GDP Data, Earnings

The Week Ahead: GDP Data, Earnings

Contributor Ken Shreve takes a look at economic data and earnings reports scheduled for this week.

Biotech Is a Source of Buys

Biotech Is a Source of Buys

Alexion shows one of the most bullish long-term charts in my database.

Daily Recap of the Charts June 15

Daily Recap of the Charts June 15

Mark Sperling of T3Live review the day's market action and sets up your trading plan for the next session.

Big-Cap Health Care Winners

Big-Cap Health Care Winners

Alexion Pharmaceuticals and Intuitive Surgical are leaders in a top-performing sector.

Sitting Tight for Respectable Volume

Sitting Tight for Respectable Volume

The light volume keeps me hesitant, though here are a few recent standout names.

Bull Market in Biotech

Bull Market in Biotech

The biotechnology sector has weathered the correction and looks ready to push higher.

Fitz Bits: More Quick Bites

Fitz Bits: More Quick Bites

Here's another serving of buy-on-the-bounce trades

Mo-Mos Lose Their Mojo

Mo-Mos Lose Their Mojo

Momentum stocks are under fairly severe pressure.

The Week Ahead: Housing Data, GDP and Earnings

The Week Ahead: Housing Data, GDP and Earnings

Contributor Ken Shreve takes a look at economic data and earnings reports scheduled for the coming week.

Not for the Faint of Heart

Not for the Faint of Heart

The high-fliers I have been showing can reap huge returns, but make sure you can handle the volatility.

Fitz Bits: Stay Long Alexion

Fitz Bits: Stay Long Alexion

The shares are highly likely to test $100. Just keep a trailing stop on any existing positions.

Look for Resting Stocks

Look for Resting Stocks

The virtuous cycle of overrunning price targets is in effect.

Alexion Pharmaceuticals upgraded at UBS

The Cure for Alexion

With only one drug on the market, the pharmaceutical company is expanding its pipeline.

The Day Ahead: Pulling Back

The Day Ahead: Pulling Back

News that Greece will need further austerity measures dragged down world markets and U.S. futures.

Alexion Pharma upgraded at Baird

The Day Ahead: Positioning for 'Jobs Friday'

The Day Ahead: Positioning for 'Jobs Friday'

Stocks were poised for a moderately higher ahead of this highly anticipated monthly event.

Squinting for Playable Stocks

Squinting for Playable Stocks

Despite the massive upsurge, there are still a few interesting setups to consider here.

Searching for a Pulse

Searching for a Pulse

It's not that the market action is bad, it just isn't lively enough to support aggressive action.

Scrutinize Those Breakouts

Scrutinize Those Breakouts

Some breakouts, like that of Apple lately, cannot be taken at face value -- especially if they lack volume.

Strong Volume Equals a Strong Foundation

Strong Volume Equals a Strong Foundation

EBIX broke out on Tuesday in heavy volume, which hints at institutional buying in this stock.

Off the Charts

Off the Charts

Keep your risk down at this point as the market still has a lot to prove.